Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoproliferative Disorders × Gemcitabine × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 149 Carcinoma, Non-Small-Cell Lung 93 Neoplasms 56 Breast Neoplasms 50 Urinary Bladder Neoplasms 47 Neoplasm Metastasis 42 Lung Neoplasms 41 Ovarian Neoplasms 35 Cholangiocarcinoma 30 Lymphoma 20 Sarcoma 19 Fallopian Tube Neoplasms 19 Lymphoma, Large B-Cell, Diffuse 18 Gallbladder Neoplasms 18 Biliary Tract Neoplasms 18 Recurrence 15 Lymphoma, Non-Hodgkin 15 Hodgkin Disease 13 Carcinoma, Transitional Cell 13 Adenocarcinoma 13 Carcinoma 12 Bile Duct Neoplasms 12 Colorectal Neoplasms 10 Head and Neck Neoplasms 8 Carcinoma, Renal Cell 8 Urethral Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Carcinoma, Ovarian Epithelial 7 Adenocarcinoma of Lung 7 Uterine Cervical Neoplasms 6

Interventions

blinatumomab 4 Rituximab 4 ponatinib 2 Vorinostat 2 Vincristine 2 Prednisone 2 Ifosfamide 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 Brentuximab Vedotin 2 Bortezomib 2 tetulomab tetraxetan lu-177 1 pegaspargase 1 ibrutinib 1 ibritumomab tiuxetan 1 durvalumab 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 acalabrutinib 1 Methotrexate 1 Melphalan 1 Lutetium 1 Lenalidomide 1 KW-2478 1 Imatinib Mesylate 1 Hsp90 inhibitor KU757 1 Dexamethasone 1 Daunorubicin 1 Cytarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡